• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低位直肠癌患者(临床 II/III 期)无临床侧盆淋巴结转移患者的手术部位感染的危险因素及与生存的关系:JCOG0212 数据分析。

Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212.

机构信息

Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, 6-7-1, Nishi-Shinjyuku Shinjyuku-ku, Tokyo, 160-0023, Japan.

Department of Surgery, Tochigi Cancer Center, Tochigi, Japan.

出版信息

Clin Exp Metastasis. 2021 Oct;38(5):459-466. doi: 10.1007/s10585-021-10117-8. Epub 2021 Aug 18.

DOI:10.1007/s10585-021-10117-8
PMID:34406563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8510931/
Abstract

This study aimed to examine the risk factors for surgical site infection (SSI) and the association of that with recurrence in JCOG0212. The results for secondary endpoints showed that compared with the mesorectal excision (ME) alone group, ME with lateral lymph node dissection (LLND) group showed significantly longer operative time and significantly higher blood loss. These results suggested that LLND was a risk factor for SSI. All 701 patients registered in JCOG0212 were analyzed in this study. Wound infection was defined as incisional/deep SSI, and pelvic abscess and anastomotic leakage were defined as organ/space SSI. The risk factors for the incidence of SSI and the effect of SSI on relapse-free survival (RFS) were investigated. Multivariable odds ratio of Grade 2 or higher all SSI was 0.58 [95% Confidence interval: 0.36-0.93] for female (vs. male) and that of Grade 2 or higher incisional/deep SSI was 2.24 [1.03-4.86] for blood infusion. For RFS, patients with Grade 3 or higher all SSI showed poor prognosis (multivariable hazard ratio: 1.66 [1.03-2.68]). LLND is not significant factor for the incidence of all SSI. Male sex might be a risk factor of Grade 2 or higher SSI, and blood transfusion is a possible risk factor of Grade 2 or higher incisional/deep SSI. Grade 3 or higher all SSI might be a significant worse prognostic factor for lower rectal cancer.

摘要

本研究旨在探讨手术部位感染(SSI)的危险因素及其与 JCOG0212 复发的关系。次要终点结果表明,与单纯直肠系膜切除术(ME)组相比,ME 加侧方淋巴结清扫(LLND)组的手术时间明显延长,出血量明显增加。这些结果提示 LLND 是 SSI 的一个危险因素。本研究对 JCOG0212 登记的所有 701 例患者进行了分析。切口/深部 SSI 定义为切口感染,盆腔脓肿和吻合口漏定义为器官/间隙 SSI。本研究探讨了 SSI 发生率的危险因素及 SSI 对无复发生存(RFS)的影响。多变量比值比(OR)显示,女性(vs. 男性)所有 SSI 2 级或以上的风险为 0.58(95%置信区间:0.36-0.93),输血为 2 级或以上切口/深部 SSI 的风险为 2.24(1.03-4.86)。对于 RFS,所有 SSI 3 级或以上的患者预后较差(多变量风险比:1.66[1.03-2.68])。LLND 不是所有 SSI 发生率的显著因素。男性可能是 SSI 2 级或以上的危险因素,输血可能是 SSI 2 级或以上切口/深部的危险因素。所有 SSI 3 级或以上可能是低位直肠癌预后不良的显著因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77dd/8510931/39f394f58ec1/10585_2021_10117_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77dd/8510931/39f394f58ec1/10585_2021_10117_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/77dd/8510931/39f394f58ec1/10585_2021_10117_Fig1_HTML.jpg

相似文献

1
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212.低位直肠癌患者(临床 II/III 期)无临床侧盆淋巴结转移患者的手术部位感染的危险因素及与生存的关系:JCOG0212 数据分析。
Clin Exp Metastasis. 2021 Oct;38(5):459-466. doi: 10.1007/s10585-021-10117-8. Epub 2021 Aug 18.
2
Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.中下段直肠癌临床 II/III 期行直肠系膜全切除加或不加侧方淋巴结清扫术(JCOG0212):一项多中心、随机对照、非劣效性临床试验。
Ann Surg. 2017 Aug;266(2):201-207. doi: 10.1097/SLA.0000000000002212.
3
Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.中低位直肠癌行直肠系膜切除术联合或不联合侧方淋巴结清扫的术后发病率和死亡率(JCOG0212):来自一项多中心、随机对照、非劣效性试验的结果。
Lancet Oncol. 2012 Jun;13(6):616-21. doi: 10.1016/S1470-2045(12)70158-4. Epub 2012 May 15.
4
Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).临床无侧盆淋巴结转移(临床 II/III 期)患者发生病理性侧盆淋巴结转移的预测因素:来自临床试验(JCOG0212)的数据分析。
Eur J Surg Oncol. 2019 Mar;45(3):336-340. doi: 10.1016/j.ejso.2018.11.016. Epub 2018 Nov 20.
5
Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).直肠系膜切除联合或不联合侧方淋巴结清扫术治疗直肠癌的随机临床试验的长期随访结果(JCOG0212)。
Br J Surg. 2020 Apr;107(5):586-594. doi: 10.1002/bjs.11513. Epub 2020 Mar 12.
6
Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.直肠癌新辅助放化疗后选择性侧方淋巴结清扫。
World J Gastroenterol. 2020 Jun 7;26(21):2877-2888. doi: 10.3748/wjg.v26.i21.2877.
7
Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).直肠癌手术后的尿功能障碍:中直肠切除加与不加侧方淋巴结清扫治疗临床 II 期或 III 期低位直肠癌的随机试验结果(日本临床肿瘤学组研究,JCOG0212)。
Eur J Surg Oncol. 2018 Apr;44(4):463-468. doi: 10.1016/j.ejso.2018.01.015. Epub 2018 Jan 17.
8
Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212.直肠癌手术后男性性功能障碍:一项针对低位直肠癌患者比较有或无侧方淋巴结清扫的直肠系膜切除术的随机试验结果:日本临床肿瘤学会研究JCOG0212
Eur J Surg Oncol. 2016 Dec;42(12):1851-1858. doi: 10.1016/j.ejso.2016.07.010. Epub 2016 Jul 30.
9
Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy.术前放化疗治疗低位直肠癌的腹腔镜侧方盆腔淋巴结清扫术。
Surg Endosc. 2020 Mar;34(3):1425-1431. doi: 10.1007/s00464-019-07224-9. Epub 2019 Oct 18.
10
Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.对无侧方淋巴结转移可疑的进展期低位直肠癌行腹腔镜侧方淋巴结清扫术时,对侧方前哨淋巴结状态进行探索性分析以优化其处理策略。
BMC Cancer. 2021 Aug 11;21(1):911. doi: 10.1186/s12885-021-08480-6.

引用本文的文献

1
The Association Between Surgical Site Infection and Prognosis of T4 Colorectal Cancer.手术部位感染与T4期结直肠癌预后的相关性
Cureus. 2024 Aug 4;16(8):e66138. doi: 10.7759/cureus.66138. eCollection 2024 Aug.
2
Surgical Site Infections in Colorectal Cancer Surgeries: A Systematic Review and Meta-Analysis of the Impact of Surgical Approach and Associated Risk Factors.结直肠癌手术中的手术部位感染:手术方式及相关危险因素影响的系统评价和荟萃分析
Life (Basel). 2024 Jul 5;14(7):850. doi: 10.3390/life14070850.
3
Low Hartmann's procedure versus abdominoperineal resection for rectal cancer, a propensity score matching cohort study.

本文引用的文献

1
The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer.中性粒细胞与淋巴细胞比值的动态变化可预测 I-III 期结肠癌的临床结局。
Sci Rep. 2018 Jun 21;8(1):9453. doi: 10.1038/s41598-018-27896-y.
2
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.日本结直肠癌学会(JSCCR)2016年结直肠癌治疗指南。
Int J Clin Oncol. 2018 Feb;23(1):1-34. doi: 10.1007/s10147-017-1101-6. Epub 2017 Mar 27.
3
Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
低 Hartmann 手术与经腹会阴联合切除术治疗直肠癌的倾向评分匹配队列研究。
BMC Gastroenterol. 2024 Jun 5;24(1):194. doi: 10.1186/s12876-024-03244-5.
4
Incidence of surgical site infection in minimally invasive colorectal surgery.微创结直肠手术中手术部位感染的发生率
World J Gastrointest Surg. 2024 Apr 27;16(4):1121-1129. doi: 10.4240/wjgs.v16.i4.1121.
5
The association between surgical site infection and postoperative colorectal cancer recurrence and the effect of laparoscopic surgery on prognosis.手术部位感染与结直肠癌术后复发的关系及腹腔镜手术对预后的影响。
Langenbecks Arch Surg. 2024 Jan 15;409(1):40. doi: 10.1007/s00423-024-03234-x.
6
Efficacy and Safety of Radical Resection of Rectal Combined with Selective Lateral Lymph Node Dissection in the Treatment of Low Rectal under Meta-analysis.Meta 分析下直肠低位 经腹会阴联合切除联合选择性侧方淋巴结清扫的疗效及安全性
Contrast Media Mol Imaging. 2022 Sep 21;2022:8456677. doi: 10.1155/2022/8456677. eCollection 2022.
7
Systematic review and meta-analysis of the risk factors of surgical site infection in patients with colorectal cancer.结直肠癌患者手术部位感染危险因素的系统评价与Meta分析
Transl Cancer Res. 2022 Apr;11(4):857-871. doi: 10.21037/tcr-22-627.
中下段直肠癌临床 II/III 期行直肠系膜全切除加或不加侧方淋巴结清扫术(JCOG0212):一项多中心、随机对照、非劣效性临床试验。
Ann Surg. 2017 Aug;266(2):201-207. doi: 10.1097/SLA.0000000000002212.
4
Risk factors for superficial surgical site infection after elective rectal cancer resection: a multivariate analysis of 8880 patients from the American College of Surgeons National Surgical Quality Improvement Program database.择期直肠癌切除术后手术部位表浅感染的危险因素:对来自美国外科医师学会国家外科质量改进计划数据库的8880例患者的多因素分析
J Surg Res. 2017 Jan;207:205-214. doi: 10.1016/j.jss.2016.08.082. Epub 2016 Aug 31.
5
The Impact of Postoperative Complications on Long-term Oncologic Outcomes After Laparoscopic Low Anterior Resection for Rectal Cancer.术后并发症对直肠癌腹腔镜低位前切除术后长期肿瘤学结局的影响
Medicine (Baltimore). 2016 Apr;95(14):e3271. doi: 10.1097/MD.0000000000003271.
6
Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study.吻合口漏增加结直肠癌根治性切除术后远处复发和长期死亡率:一项全国性队列研究。
Ann Surg. 2014 May;259(5):930-8. doi: 10.1097/SLA.0b013e3182a6f2fc.
7
Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.中低位直肠癌行直肠系膜切除术联合或不联合侧方淋巴结清扫的术后发病率和死亡率(JCOG0212):来自一项多中心、随机对照、非劣效性试验的结果。
Lancet Oncol. 2012 Jun;13(6):616-21. doi: 10.1016/S1470-2045(12)70158-4. Epub 2012 May 15.
8
Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis.吻合口漏后结直肠癌局部复发率增加和生存率降低:系统评价和荟萃分析。
Ann Surg. 2011 May;253(5):890-9. doi: 10.1097/SLA.0b013e3182128929.
9
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis.发展中国家地方性卫生保健相关感染的负担:系统评价和荟萃分析。
Lancet. 2011 Jan 15;377(9761):228-41. doi: 10.1016/S0140-6736(10)61458-4. Epub 2010 Dec 9.
10
Indication and benefit of pelvic sidewall dissection for rectal cancer.直肠癌盆腔侧壁清扫术的适应症及益处
Dis Colon Rectum. 2006 Nov;49(11):1663-72. doi: 10.1007/s10350-006-0714-z.